propranolol has been researched along with quercetin in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (7.14) | 18.7374 |
| 1990's | 2 (14.29) | 18.2507 |
| 2000's | 7 (50.00) | 29.6817 |
| 2010's | 4 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Strassburg, CP; Tukey, RH | 1 |
| Bacsó, Z; Cianfriglia, M; Fenyvesi, F; Goda, K; Kappelmayer, J; Lustyik, G; Nagy, H; Szabó, G; Szilasi, M | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Andreani, A; Cervellati, R; Greco, E; Huang, K; Kondratyuk, TP; Leoni, A; Locatelli, A; Morigi, R; Park, EJ; Pezzuto, JM; Rambaldi, M; van Breemen, RB | 1 |
| Anderson, KW; Coll, RJ; Murphy, AJ | 1 |
| Morita, T; Motoyashiki, T; Ueki, H | 1 |
| Walgren, RA; Walle, T | 1 |
| Behar, J; Biancani, P; Cao, W; Chen, Q; Harnett, KM; Kim, N; Kirber, MT; Sohn, UD | 1 |
| Borrelli, F; Capasso, F; Capasso, R; Izzo, AA; Mascolo, N | 1 |
| Atorino, G; Aviello, G; Borrelli, F; Capasso, R; Pagano, E; Romano, B | 1 |
1 review(s) available for propranolol and quercetin
| Article | Year |
|---|---|
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic | 2000 |
13 other study(ies) available for propranolol and quercetin
| Article | Year |
|---|---|
Distinct groups of multidrug resistance modulating agents are distinguished by competition of P-glycoprotein-specific antibodies.
Topics: Adenosine Triphosphatases; Animals; Anti-Bacterial Agents; Antibodies, Monoclonal; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Binding, Competitive; Calcium Channel Blockers; Cyclosporine; Detergents; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Flow Cytometry; Fluoresceins; Humans; Ivermectin; Mice; NIH 3T3 Cells; Substrate Specificity | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Chemopreventive and antioxidant activity of 6-substituted imidazo[2,1-b]thiazoles.
Topics: Animals; Anticarcinogenic Agents; Antioxidants; Aromatase Inhibitors; Azepines; Cell Line; Cell Survival; Cells, Cultured; COS Cells; Humans; Hydrogen-Ion Concentration; Imidazoles; Inhibitory Concentration 50; Microsomes, Liver; Molecular Structure; NF-kappa B; Nitric Oxide Synthase Type II; Thiazoles | 2013 |
Inhibition of skeletal muscle sarcoplasmic reticulum CaATPase activity by calmidazolium.
Topics: Adenosine Triphosphate; Animals; Calcium-Transporting ATPases; Dose-Response Relationship, Drug; Enzyme Inhibitors; Imidazoles; Kinetics; Mathematics; Muscles; Phosphorylation; Propranolol; Quercetin; Rabbits; Sarcoplasmic Reticulum; Trifluoperazine | 1984 |
Involvement of the rapid increase in cAMP content in the vanadate-stimulated release of lipoprotein lipase activity from rat fat pads.
Topics: Adipose Tissue; Animals; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Enzyme Activation; Isoproterenol; Lipoprotein Lipase; Male; Propranolol; Quercetin; Rats; Rats, Wistar; Vanadates | 1996 |
The influence of plasma binding on absorption/exsorption in the Caco-2 model of human intestinal absorption.
Topics: Adrenergic beta-Antagonists; Antineoplastic Agents, Phytogenic; Biological Transport; Blood Proteins; Caco-2 Cells; Estradiol; Humans; Intestinal Absorption; Models, Biological; Paclitaxel; Propranolol; Quercetin | 1999 |
Ca2+-induced contraction of cat esophageal circular smooth muscle cells.
Topics: Adrenergic beta-Antagonists; Alkaloids; Animals; Antibodies; Azepines; Benzophenanthridines; Bridged-Ring Compounds; Calcium; Calcium Signaling; Cats; Dose-Response Relationship, Drug; Enzyme Inhibitors; Esophagus; Estrenes; Female; Guanosine 5'-O-(3-Thiotriphosphate); Isoenzymes; Male; Muscle Contraction; Muscle, Smooth; Myosin Light Chains; Naphthalenes; Norbornanes; Phenanthridines; Phosphodiesterase Inhibitors; Phospholipase D; Phosphorylation; Propranolol; Protein Kinase C; Protein Kinase C-epsilon; Pyrrolidinones; Quercetin; Second Messenger Systems; Thiocarbamates; Thiones; Type C Phospholipases | 2001 |
Inhibitory effect of the antidepressant St. John's wort (hypericum perforatum) on rat bladder contractility in vitro.
Topics: Acetylcholine; Adenosine Triphosphate; Animals; Anthracenes; Antidepressive Agents; Atropine; Bridged Bicyclo Compounds; Capsaicin; Depression; Electric Stimulation; Female; Haloperidol; Hypericum; Kaempferols; Male; Methysergide; Muscle Contraction; Muscle, Smooth; Naloxone; Perylene; Phentolamine; Phloroglucinol; Piperidines; Plant Extracts; Propranolol; Pyrazoles; Quercetin; Rats; Rats, Wistar; Rimonabant; Rutin; Terpenes; Tetrodotoxin; Urinary Bladder; Urinary Incontinence; Verapamil | 2004 |
Inhibitory effect of quercetin on rat trachea contractility in vitro.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Antioxidants; Benzamides; Capsaicin; Carbachol; Dose-Response Relationship, Drug; Electric Stimulation; Enzyme Inhibitors; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth; Neurokinin-1 Receptor Antagonists; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Phentolamine; Piperidines; Propranolol; Quercetin; Quinuclidines; Rats; Rats, Wistar; Receptors, Neurokinin-2; Trachea | 2009 |